Dermatology - European Medical Journal

Continue

Dermatology

Filter
8 Jan 2019

Molecular Link Between Psoriasis and Diabetes

PSORIASIS increases the risk of developing Type 2 diabetes mellitus; however, the reasons behind this link have not been reported. Now, researchers from…
30 Oct 2018

European Medical Journal Presents: EMJ Dermatology 6.1

The publication of EMJ Dermatology 6.1 is now available, containing a full review of the 27th European Academy of Dermatology and Venereology (EADV)…
8 Oct 2018

First-of-its-Kind Topical Spray Proving Effective at Treating Atopic Dermatitis

Cyclatop, a 5% cyclosporine topical spray, may be poised to deliver a significant therapeutic improvement for atopic dermatitis patients. A new study by…
8 Oct 2018

Beauticians Beware: (Meth)acrylate May Cause Contact Allergy

(Meth)acrylates are important components of acrylic nails, gel nails, and gel polish nails and could be the cause of an allergic epidemic, warns a…
9 Aug 2018

More Awareness Needed of Fungal Infection that Affects a Large Number of Women

Recurrent vulvovaginal thrush affects around 138 million women worldwide, a figure that is estimated to rise to 158 million by 2030 according to an…
10 Jul 2018

Ozenoxacin as a Novel Treatment Option for Impetigo

Ozenoxacin has been shown to be a well-tolerated and effective treatment for impetigo patients ≥2 months old, according to results of a randomised…
10 Jul 2018

Tralokinumab: A Safe and Effective Atopic Dermatitis Treatment

Tralokinumab is a fully human monoclonal antibody that has been shown to improve atopic dermatitis (AD) symptoms in patients with moderate-to-severe AD…
13 Jun 2018

Janssen’s Tremfya®▼ (guselkumab) receives its first two positive Health Technology Assessments in Europe

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the United Kingdom’s National Institute for Health and Care Excellence…
We’ve noticed you’re accessing
from North/South America.